Ketotifen Fumarate

富马酸酮替芬

Report date: 2023/04/21 17:24:32
NME

Base Information

Drug NameKetotifen Fumarate
Drug Alias Nameketotifeno富马酸酮替酚ketotifenum甲哌噻庚酮富马酸盐延胡索酸酯 +[13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsNeuroinflammatory DiseasesUpper Limb FractureChronic Pain +[15
Global Approved IndicationsConjunctivitis, AllergicRhinitis, AllergicAsthma
Approved Indications in ChinaRhinitis, AllergicAsthma
Original Approved Country/TerritorySwitzerland
Original Approved Date1978/01/01
Country/TerritoryCanadaUnited StatesSwitzerland +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active IndicationsNeuroinflammatory DiseasesUpper Limb FracturePruritus +[11
Inactive IndicationsChronic PainRefractive ErrorsFibromyalgia +[4

Other Information

ATC CodeR06AX17S01GX08